16.12.2012 Aufrufe

Psychische Erkrankungen in der Lebensspanne ... - DGPPN

Psychische Erkrankungen in der Lebensspanne ... - DGPPN

Psychische Erkrankungen in der Lebensspanne ... - DGPPN

MEHR ANZEIGEN
WENIGER ANZEIGEN

Erfolgreiche ePaper selbst erstellen

Machen Sie aus Ihren PDF Publikationen ein blätterbares Flipbook mit unserer einzigartigen Google optimierten e-Paper Software.

Topic 12 G Bildgebung, Neurophysiologie, Neuropsychologie // Bra<strong>in</strong> Imag<strong>in</strong>g, neurophysiology, neuropsychology<br />

of dementia with more than 70 % accuracy. Automated high-resolution<br />

image process<strong>in</strong>g us<strong>in</strong>g deformation based morphometry<br />

together with multivariate analysis predicts of onset of dementia <strong>in</strong><br />

at risk stages with more than 80 % accuracy. Functional MRI <strong>in</strong> the<br />

rest<strong>in</strong>g state may evolve as easily accessible marker of cortical functional<br />

connectivity, but requires further study. Detection of subcortical<br />

fiber tract <strong>in</strong>tegrity may be a useful adjunct to functional and<br />

structural imag<strong>in</strong>g, but has not yet fully been explored as diagnostic<br />

or outcome marker. F<strong>in</strong>ally, new <strong>in</strong> vivo tracer of amyloid plaque<br />

load with positron emission tomography may identify amyloid pathology<br />

<strong>in</strong> asymptomatic subjects as risk marker of AD and may be<br />

useful to detect effects of amyloid lower<strong>in</strong>g treatment strategies <strong>in</strong><br />

vivo.<br />

Discussion / Results: Multimodal imag<strong>in</strong>g draws a comprehensive<br />

picture of amyloid pathology, cortical connectivity and neuroanl<br />

degeneration and will be important <strong>in</strong> the near future to enhance<br />

the power of cl<strong>in</strong>ical prevention trials and to better un<strong>der</strong>stand the<br />

effect of amyloid pathology on cognitive decl<strong>in</strong>e. The broad implementation<br />

of advanced neuroimag<strong>in</strong>g techniques <strong>in</strong> cl<strong>in</strong>ical rout<strong>in</strong>e,<br />

however, very likely will depend on the availability of next generation<br />

treatment approaches that aim to modify un<strong>der</strong>ly<strong>in</strong>g<br />

disease processes.<br />

002<br />

Neuroimag<strong>in</strong>g <strong>in</strong> neuropsychiatric disor<strong>der</strong>s: differential diagnosis<br />

and prediction of cl<strong>in</strong>ical course<br />

Oliver Pogarell (LMU München, Kl<strong>in</strong>ik für Psychiatrie)<br />

Introduction: The neurobiological characterisation of psychiatric<br />

disor<strong>der</strong>s provides <strong>in</strong>sight <strong>in</strong>to bra<strong>in</strong> functional alterations and relevant<br />

pathomechanisms, and is a major issue of current research.<br />

Nowadays there is <strong>in</strong>creas<strong>in</strong>g evidence that neurobiological parameters<br />

can be used as diagnostic tools and to warrant or to validate<br />

pharmacological treatment decisions. Clear pathophysiological hypotheses<br />

with respect to neuronal activity or bra<strong>in</strong> neurochemistry<br />

provide a scientific basis for the development of differential treatment<br />

strategies and the evaluation of the course of the disor<strong>der</strong> un<strong>der</strong><br />

treatment. Thus the assessment of bra<strong>in</strong> activity at rest or upon<br />

stimulation <strong>in</strong>clud<strong>in</strong>g un<strong>der</strong>ly<strong>in</strong>g neurochemical alterations can<br />

help to facilitate the differential diagnosis and subsequent therapeutic<br />

decisions.<br />

Method: Neurophysiology and neuroimag<strong>in</strong>g are the key tools to<br />

evaluate bra<strong>in</strong> functional disor<strong>der</strong>s and consequently to monitor<br />

neurobiological treatment effects. In particular, a comb<strong>in</strong>ation of<br />

complementary methods can add to the cl<strong>in</strong>ical assessment of psychopathology<br />

with respect to differential diagnoses and treatment<br />

decisions. Furthermore, these methods help to prove pathophysiological<br />

concepts.<br />

Discussion / Results: Both neurophysiological and functional neuroimag<strong>in</strong>g<br />

techniques have been used to discrim<strong>in</strong>ate diagnostic<br />

and therapeutic subgroups of neuropsychiatric patients and have<br />

been assessed regard<strong>in</strong>g prognostic and predictive properties. Studies<br />

<strong>in</strong> patients with depression, obsessive compulsive disor<strong>der</strong>, attention<br />

deficit or emotional <strong>in</strong>stability provide evidence of different<br />

pathophysiological mechanisms of both categories of psychiatric<br />

disor<strong>der</strong>s and psychopathological dimensions. Therefore the data<br />

might be useful <strong>in</strong> cl<strong>in</strong>ical application – <strong>in</strong> terms of diagnosis, evaluation<br />

of the course or prediction of subjects‘ responses to treatment.<br />

003<br />

Neuroimag<strong>in</strong>g <strong>in</strong> major psychosis: neuromarkers for validation<br />

and reformation of psychiatric classification systems<br />

Oliver Gruber (Universitätskl<strong>in</strong>ikum Gött<strong>in</strong>gen, Kl<strong>in</strong>ik für Psychiatrie)<br />

Introduction: In psychiatric research, neuroimag<strong>in</strong>g techniques<br />

are usually applied <strong>in</strong> or<strong>der</strong> to detect morphological and / or functional<br />

(i. e. pathophysiological) bra<strong>in</strong> abnormalities <strong>in</strong> patient<br />

groups. These group abnormalities may either be common to different<br />

psychiatric disor<strong>der</strong>s, e. g. to different types of major psychoses<br />

(schizophrenia, schizoaffective disor<strong>der</strong>, bipolar disor<strong>der</strong> and unipolar<br />

major depression), or they may be specific to one of these<br />

diag nostic categories accord<strong>in</strong>g to current classifications systems,<br />

which could help to confirm the biological validity of these diagnoses.<br />

On the other hand, the same neuroimag<strong>in</strong>g techniques can<br />

also be used <strong>in</strong> or<strong>der</strong> to search for neuromarkers that may be common<br />

to subgroups of patients <strong>in</strong>dependent of their diagnosis<br />

accord <strong>in</strong>g to current classification. If this approach of def<strong>in</strong><strong>in</strong>g <strong>in</strong>termediate<br />

psychiatric phenotypes accord<strong>in</strong>g to neuropathophysiological<br />

markers proves to be successful, this could advance the<br />

identification of pathogenetic pathways and could lead to a reformation<br />

of diagnostic systems based on etiology and pathogenesis.<br />

Method: Different methods may contribute to category-<strong>in</strong>dependent<br />

search for endophenotypic neuropathophysiological markers<br />

us<strong>in</strong>g neuroimag<strong>in</strong>g. Statistical analyses of, for <strong>in</strong>stance, bra<strong>in</strong> activation<br />

abnormalities <strong>in</strong> s<strong>in</strong>gle patients may be a first step <strong>in</strong> the<br />

attempt to identify subgroups of patients with a more homogeneous<br />

un<strong>der</strong>ly<strong>in</strong>g pathophysiology. More advanced methods <strong>in</strong>clude<br />

pattern classification and related approaches.<br />

Discussion / Results: There is already ample evidence for neurobiological<br />

heterogeneity with<strong>in</strong> the diagnostic categories accord<strong>in</strong>g<br />

to current psychiatric classification systems. In this talk, examples<br />

for this heterogeneity will be <strong>in</strong>troduced with particular emphasis<br />

on neuroimag<strong>in</strong>g f<strong>in</strong>d<strong>in</strong>gs. Furthermore, recent examples for the<br />

success of pattern classification methods <strong>in</strong> detect<strong>in</strong>g common<br />

neuropathophysiological markers <strong>in</strong> neuroimag<strong>in</strong>g data will be<br />

presented. In or<strong>der</strong> to further evaluate the possible diagnostic value<br />

of neuroimag<strong>in</strong>g markers with regard to future psychiatric diagnosis<br />

based on etiology and pathogenesis it will also be important to<br />

acquire normative data on these neuromarkers.<br />

004<br />

Neuroimag<strong>in</strong>g <strong>in</strong> depression and schizophrenia: evaluation of therapeutic<br />

approaches<br />

Ute Habel (Universitätskl<strong>in</strong>ik Aachen, Psychiatrie und Psychotherapie)<br />

Introduction: Neuropsychological as well as neuroimag<strong>in</strong>g data<br />

reveal a complex dysfunctional <strong>in</strong>teraction <strong>in</strong> schizophrenia but<br />

also <strong>in</strong> depressive patients, where especially subcortical-limbic but<br />

also frontal and c<strong>in</strong>gular regions show aberrant activation patterns<br />

dur<strong>in</strong>g cognitive as well as emotional functions. Hence, regions of<br />

major importance <strong>in</strong> cognition but also emotion regulation and<br />

<strong>in</strong>te gration are affected.<br />

Method: Longitud<strong>in</strong>al fMRI studies evaluate the possibility to reduce<br />

cognitive and emotional impairments with specific psychological<br />

therapies. In schizophrenia, a cognitive tra<strong>in</strong><strong>in</strong>g was evaluated<br />

as well as an emotion recognition tra<strong>in</strong><strong>in</strong>g. In depression a standardized<br />

humor tra<strong>in</strong><strong>in</strong>g has been evaluated on the dysfunctional correlates<br />

dur<strong>in</strong>g humorour cartoon process<strong>in</strong>g.<br />

Discussion / Results: A complex pattern of hypo- and hyperactivations<br />

emerged <strong>in</strong> a subcortical-limbic as well as cortical network <strong>in</strong><br />

dependence of task requirements. Results of the longitud<strong>in</strong>al studies<br />

document the therapeutic effects, normally seen on a behavioral<br />

level, <strong>in</strong> the un<strong>der</strong>ly<strong>in</strong>g neuronal substrates and demonstrate the<br />

specific efficacy of behavioral therapies. However, concern<strong>in</strong>g psy-<br />

267

Hurra! Ihre Datei wurde hochgeladen und ist bereit für die Veröffentlichung.

Erfolgreich gespeichert!

Leider ist etwas schief gelaufen!